Seeing terms such as “prostate adenocarcinoma,” “Gleason score,” or “Grade Group” on your pathology report after a prostate biopsy can be alarming.
Many patients have a similar initial reaction:
“I have cancer. What happens now?”
The most important thing to understand is this:
Not all prostate cancers are the same.
Today, many patients diagnosed with prostate cancer live long and healthy lives. Some patients may only require careful monitoring, while others may benefit from surgery or other treatment options.
For this reason, a diagnosis of prostate cancer on biopsy does not automatically mean that immediate surgery is necessary.
Prostate cancer is one of the most common cancers in men.
At the same time, it is also one of the most variable cancers in terms of behavior.
Some tumors grow very slowly, while others may behave more aggressively.
Therefore, the first step is to accurately determine the characteristics of the disease.
A prostate biopsy report typically includes information about:
These findings are used to determine the risk category of the disease.
The Gleason score is a grading system that evaluates how prostate cancer cells appear under the microscope.
In general:
As the Gleason score increases, the likelihood of aggressive tumor behavior also increases.
In addition to the Gleason score, the Grade Group classification system is now widely used.
Grade Groups range from Grade Group 1 to Grade Group 5.
This system helps physicians and patients better understand the biological behavior of the disease.
No.
This is one of the most common misconceptions about prostate cancer.
When deciding on treatment, several factors are considered together, including:
For some patients, close monitoring may be recommended instead of immediate treatment.
For selected patients with low-risk prostate cancer, active surveillance may be recommended instead of surgery or radiation therapy.
Under this approach, patients are monitored with:
The goal is to avoid unnecessary treatment while preserving quality of life.
Not every patient with prostate cancer requires advanced imaging studies.
However, additional evaluation may be recommended for patients with intermediate- or high-risk disease.
These tests may include:
The purpose is to determine whether the disease has spread beyond the prostate.
One of the most commonly used treatments for prostate cancer is robotic radical prostatectomy.
During this procedure:
The advantages of robotic surgery may include:
Yes.
For some patients, radiation therapy may be an effective treatment option.
When choosing a treatment strategy, several factors are considered, including:
The goal of modern prostate cancer management is not to provide the same treatment to every patient.
Instead, the objective is to develop a personalized treatment plan based on the characteristics of the disease and the individual patient’s expectations and needs.
For this reason, patients diagnosed with prostate cancer should undergo a thorough evaluation by an experienced urology specialist.
Today, treatment outcomes for prostate cancer diagnosed at an early stage are highly successful.
Many patients are able to return to their normal lives after treatment and continue to live healthy and active lives for many years.
For this reason, a diagnosis of prostate cancer should not be viewed as a reason to lose hope, but rather as the starting point for careful evaluation and appropriate treatment planning.
A diagnosis of prostate cancer on biopsy is an important finding, but not all prostate cancers behave the same way, and not every patient requires the same treatment.
Today, modern treatment options such as active surveillance, robotic surgery, radiation therapy, and other advanced therapies allow physicians to provide individualized treatment strategies tailored to each patient’s specific disease characteristics.
If prostate cancer has been detected on your biopsy, the most appropriate next step is a detailed assessment of your disease risk and the development of a personalized treatment plan.
Assoc. Prof. Dr. Serdar Yalçın
Urology Specialist
Prostate Cancer • Robotic Radical Prostatectomy • MRI Fusion Prostate Biopsy • Urologic Oncology • Robotic Urology
Bu makalenin DoktorTakvimi web sitesinde yayımlanması, yazarın açık izniyle yapılmaktadır. Web sitesindeki tüm içerikler, fikri ve sınai mülkiyet mevzuatı kapsamında uygun şekilde korunmaktadır.
DocPlanner Teknoloji A.Ş. web sitesi tıbbi tavsiye sunmaz. Bu sayfanın içeriği, metinler, grafikler, görseller ve diğer materyaller de dahil olmak üzere, yalnızca bilgilendirme amacıyla oluşturulmuştur ve tıbbi tavsiye, teşhis veya tedavinin yerini almak amacı taşımaz. Herhangi bir sağlık sorununuzla ilgili şüpheniz varsa, bir uzmana danışınız.
15/06/2026
11/06/2026
11/06/2026